Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
DFTX Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/dftx/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Definium Therapeutics, Inc. (DFTX) Insider Trading

6 open-market trades reported since Sep 4, 2026: 0 purchases worth $0 and 6 sales worth $3.02M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Robert BarrowCEO0$02$1.88MSep 29, 2026
Mark SullivanGeneral Counsel0$01$514KSep 29, 2026
Daniel KarlinChief Medical Officer0$01$397KSep 29, 2026
Brandi RobertsCFO0$01$123KSep 29, 2026
Matthew T. WileyChief Commercial Officer0$01$113KSep 29, 2026

All trades

DFTX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 29Sep 25Robert BarrowCEOCEO▼ SELL10b5-131,55036.57$1.15M−1.4%Form 4 ↗
Sep 29Sep 25Mark SullivanGeneral CounselGeneral Counsel▼ SELL10b5-114,05136.57$514K−2.8%Form 4 ↗
Sep 29Sep 25Daniel KarlinChief Medical OfficerChief Medical Officer▼ SELL10b5-110,85336.57$397K−1.4%Form 4 ↗
Sep 29Sep 25Brandi RobertsCFOCFO▼ SELL10b5-13,37736.57$123K−0.8%Form 4 ↗
Sep 29Sep 25Matthew T. WileyChief Commercial OfficerChief Commercial Officer▼ SELL10b5-13,09736.57$113K−0.9%Form 4 ↗
Sep 4Sep 3Robert BarrowCEOCEO▼ SELL10b5-119,02337.94$722K−1.3%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings